Literature DB >> 16539877

Surgical treatment of obesity.

William Johnson1, Eric DeMaria.   

Abstract

Obesity has emerged as one of the most complex and debilitating diseases affecting the world's population. It is estimated that more than two thirds of Americans are overweight and more than 20% are obese. This disease is associated with many morbid conditions, including hypertension, coronary artery disease, hypoventilation, sleep apnea syndrome, diabetes mellitus, and an increased incidence of certain malignancies. Medical interventions for achieving and maintaining significant weight loss have generally failed, leaving surgery as the only effective treatment for durable weight loss. A number of surgical options are available today and can be grouped into two categories based on the mechanism of how the weight loss is achieved. Restrictive procedures include vertical banded gastroplasty (VBG), adjustable gastric banding (AGB), and Roux-en-Y gastric bypass (RYGB), although the latter does have some altered absorption as well. Largely malabsorptive procedures include biliopancreatic diversion (BPD) and biliopancreatic diversion with duodenal switch (BPD-DS). Whereas VBG has largely fallen out of favor due to inadequate long-term weight loss, the other procedures have proven successful in achieving and maintaining adequate weight loss. In addition, each has proven successful in reversing or ameliorating many of the comorbidities associated with obesity. RYGB is the most common procedure performed in the United States and is considered the gold standard. It has the best short- and long-term results for safety, efficacy, and durability, and it has been proven to be superior in results to those for AGB. In experienced hands, this technically challenging procedure can now be performed laparoscopically. This method has the same weight loss and health benefits as the open procedure while achieving all the added benefits of a minimally invasive approach. Long-term data seem to support the malabsorptive procedures as most effective in the superobese. All the procedures require compliance and long-term nutritional follow-up.

Entities:  

Year:  2006        PMID: 16539877     DOI: 10.1007/s11938-006-0035-2

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  50 in total

1.  Evolution of minimally invasive bariatric surgery.

Authors:  Jon C Gould; Bradley J Needleman; E Christopher Ellison; Peter Muscarella; Carol Schneider; W Scott Melvin
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

2.  A comparison of diet and exercise therapy versus laparoscopic Roux-en-Y gastric bypass surgery for morbid obesity: a decision analysis model.

Authors:  Emma J Patterson; David R Urbach; Lee L Swanström
Journal:  J Am Coll Surg       Date:  2003-03       Impact factor: 6.113

Review 3.  Laparoscopic biliopancreatic diversion with duodenal switch.

Authors:  Michel Gagner; Ronald Matteotti
Journal:  Surg Clin North Am       Date:  2005-02       Impact factor: 2.741

4.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

5.  Sleep disturbance and obesity: changes following surgically induced weight loss.

Authors:  J B Dixon; L M Schachter; P E O'Brien
Journal:  Arch Intern Med       Date:  2001-01-08

6.  Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution.

Authors:  J Dargent
Journal:  Obes Surg       Date:  1999-10       Impact factor: 4.129

7.  Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity. The first 116 cases.

Authors:  P K Papasavas; F D Hayetian; P F Caushaj; R J Landreneau; J Maurer; R J Keenan; R F Quinlin; D J Gagné
Journal:  Surg Endosc       Date:  2002-09-23       Impact factor: 4.584

8.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

9.  Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

Authors:  M L Shiffman; H J Sugerman; J M Kellum; W H Brewer; E W Moore
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

Review 10.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

View more
  6 in total

Review 1.  The importance of the length of the limbs for gastric bypass patients--an evidence-based review.

Authors:  Dimitrios Stefanidis; Timothy S Kuwada; Keith S Gersin
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

2.  Laparoscopic assisted ERCP in Roux-en-Y gastric bypass (RYGB) surgery patients.

Authors:  Atif Saleem; Michael J Levy; Bret T Petersen; Florencia G Que; Todd H Baron
Journal:  J Gastrointest Surg       Date:  2011-11-01       Impact factor: 3.452

3.  Long-term results of laparoscopic Roux-en-Y Gastric bypass: evaluation after 9 years.

Authors:  Jacques Himpens; Anneleen Verbrugghe; Guy-Bernard Cadière; Wouter Everaerts; Jan-Willem Greve
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

4.  The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss.

Authors:  J Fleischer; E M Stein; M Bessler; M Della Badia; N Restuccia; L Olivero-Rivera; D J McMahon; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

5.  Small Intestinal Length Associates with Serum Triglycerides Before and After LRYGB.

Authors:  Pirjo Käkelä; Ville Männistö; Maija Vaittinen; Sari Venesmaa; Vesa Kärjä; Kirsi Virtanen; Hannu Paajanen; Jussi Pihlajamäki
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

6.  Study protocol of the DUCATI-study: a randomized controlled trial investigating the optimal common channel length in laparoscopic gastric bypass for morbid obese patients.

Authors:  Ralph P M Gadiot; Brechtje A Grotenhuis; L Ulas Biter; Martin Dunkelgrun; Hans J J Zengerink; Pierre B G M Feskens; Guido H H Mannaerts
Journal:  BMC Obes       Date:  2015-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.